CD34(+) selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome
Hm. Lazarus et al., CD34(+) selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome, BONE MAR TR, 25(5), 2000, pp. 559-566
Citations number
40
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
The purpose of this study was to investigate whether storing mobilized peri
pheral blood progenitor cell (PBPC) collections overnight before CD34(+) se
lection may delay platelet count recovery after high-dose chemotherapy and
CD34(+)-enriched PBPC re-infusion. Lymphoma patients underwent PBPC mobiliz
ation with cyclophosphamide 4 g/m(2) i.v. and G-CSF 10 mu g/kg/day subcutan
eously. Patients were prospectively randomized to have each PBPC collection
enriched for CD34(+) cells with the CellPro CEPRATE SC System either immed
iately or after overnight storage at 4 degrees C, Thirty-four patients were
randomized to overnight storage and 34 to immediate processing of PBPC; 15
were excluded from analysis due to tumor progression or inadequate CD34(+)
cell mobilization, PBPC from 23 patients were stored overnight, while 30 s
ubjects underwent immediate CD34(+) selection and cryopreservation, Median
yield of CD34(+) enrichment was 43.6% in the immediate processing group com
pared to 39.1% in the overnight storage group (P = 0.339). Neutrophil recov
ery >500 x 10(9)/l occurred a median of 11 days (range 9-16 days) in the ov
ernight storage group compared to 10.5 days (range 9-21 days) in the immedi
ate processing group (P = 0.421). Median day to platelet transfusion indepe
ndence was 13 (range 7-43) days in the overnight storage group vs 13.5 (ran
ge 8-35) days in those assigned to immediate processing (P = 0.933). We con
clude that storage of PBPC overnight at 4 degrees C allows pooling of conse
cutive-day collections resulting in decreased costs and processing time wit
hout compromising neutrophil and platelet engraftment after infusion of CD3
4(+)-selected progenitor cells.